| Primary |
| Product Used For Unknown Indication |
32.7% |
| Bronchitis |
7.1% |
| Pyrexia |
6.2% |
| Infection |
5.3% |
| Rhinitis |
5.3% |
| Otitis Media |
4.4% |
| Pharyngitis |
4.4% |
| Urinary Tract Infection |
4.4% |
| Drug Use For Unknown Indication |
3.5% |
| Sinusitis |
3.5% |
| Angina Pectoris |
2.7% |
| Myocardial Infarction |
2.7% |
| Pneumonia |
2.7% |
| Schizophrenia |
2.7% |
| Tonsillitis |
2.7% |
| Toothache |
2.7% |
| Hyperuricaemia |
1.8% |
| Lower Respiratory Tract Infection |
1.8% |
| Nasopharyngitis |
1.8% |
| Otitis Media Acute |
1.8% |
|
| Thrombocytopenia |
11.1% |
| Anaphylactic Shock |
6.7% |
| Autoimmune Hepatitis |
6.7% |
| Monoplegia |
6.7% |
| Sleep Disorder |
6.7% |
| Autoimmune Thyroiditis |
4.4% |
| Dizziness |
4.4% |
| Hepatitis Fulminant |
4.4% |
| Hyperhidrosis |
4.4% |
| Kounis Syndrome |
4.4% |
| Rash Pruritic |
4.4% |
| Streptococcal Infection |
4.4% |
| Syndactyly |
4.4% |
| Tachycardia |
4.4% |
| Thrombocytosis |
4.4% |
| Type Iv Hypersensitivity Reaction |
4.4% |
| Urticaria |
4.4% |
| Vomiting |
4.4% |
| Acute Myocardial Infarction |
2.2% |
| Convulsion |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
52.2% |
| Drug Use For Unknown Indication |
5.3% |
| Pyrexia |
5.1% |
| Upper Respiratory Tract Infection |
4.7% |
| Angioimmunoblastic T-cell Lymphoma |
3.5% |
| Urinary Tract Infection |
3.4% |
| Malignant Glioma |
3.2% |
| Infection |
2.6% |
| Nasopharyngitis |
2.4% |
| Oral Candidiasis |
2.1% |
| Colorectal Cancer Metastatic |
1.9% |
| Foetal Exposure During Pregnancy |
1.9% |
| Rhinitis |
1.9% |
| Infective Exacerbation Of Chronic Obstructive Airways Disease |
1.6% |
| Cough |
1.4% |
| Gastroenteritis |
1.4% |
| Influenza |
1.4% |
| Colitis Ulcerative |
1.3% |
| Inflammation |
1.3% |
| Intestinal Perforation |
1.3% |
|
| White Blood Cell Count Increased |
11.5% |
| Diarrhoea |
9.2% |
| Drug Hypersensitivity |
8.0% |
| Prothrombin Time Prolonged |
6.9% |
| Toxic Epidermal Necrolysis |
6.9% |
| Anaphylactic Shock |
5.7% |
| Liver Disorder |
5.7% |
| Treatment Failure |
5.7% |
| Urticaria |
5.7% |
| Stevens-johnson Syndrome |
4.6% |
| Hepatitis Fulminant |
3.4% |
| Rash |
3.4% |
| Shock |
3.4% |
| Sleep Disorder |
3.4% |
| Thrombocytopenia |
3.4% |
| Tourette's Disorder |
3.4% |
| Agranulocytosis |
2.3% |
| Angioedema |
2.3% |
| Autoimmune Hepatitis |
2.3% |
| Blood Immunoglobulin G Increased |
2.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
25.4% |
| Product Used For Unknown Indication |
13.6% |
| Hypertension |
6.6% |
| Prophylaxis |
5.5% |
| Pain |
5.0% |
| Rheumatoid Arthritis |
4.9% |
| Asthma |
3.8% |
| Cystic Fibrosis |
3.7% |
| Hiv Infection |
3.4% |
| Lower Respiratory Tract Infection |
3.3% |
| Crohn's Disease |
3.0% |
| Depression |
2.9% |
| Upper Respiratory Tract Infection |
2.7% |
| Urinary Tract Infection |
2.7% |
| Infection |
2.6% |
| Rhinitis Allergic |
2.4% |
| Sinusitis |
2.3% |
| Multiple Myeloma |
2.1% |
| Pyrexia |
2.1% |
| Constipation |
1.8% |
|
| Wound Infection Staphylococcal |
10.0% |
| Vomiting |
9.1% |
| Hyperkalaemia |
8.2% |
| Urinary Tract Infection |
7.3% |
| Organ Failure |
5.5% |
| Weight Increased |
5.5% |
| White Blood Cell Count Increased |
5.5% |
| Lower Respiratory Tract Infection |
4.5% |
| Palpitations |
4.5% |
| Viral Infection |
4.5% |
| Death |
3.6% |
| Dyspnoea |
3.6% |
| Pain |
3.6% |
| Pituitary-dependent Cushing's Syndrome |
3.6% |
| Pyrexia |
3.6% |
| Rhabdomyolysis |
3.6% |
| Silent Myocardial Infarction |
3.6% |
| Stomatitis |
3.6% |
| Uveitis |
3.6% |
| Agranulocytosis |
2.7% |
|
| Interacting |
|
|
